{"id":"NCT01077973","sponsor":"Pfizer","briefTitle":"Study Evaluating A Novel Ibuprofen Formulation In Episodic Tension-Type Headache","officialTitle":"Evaluation Of The Efficacy Of A Novel Ibuprofen Formulation In The Treatment Of Episodic Tension-Type Headache","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-03","primaryCompletion":"2010-10","completion":"2010-10","firstPosted":"2010-03-01","resultsPosted":"2012-08-20","lastUpdate":"2012-08-20"},"enrollment":200,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Pain"],"interventions":[{"type":"DRUG","name":"Novel Ibuprofen","otherNames":[]},{"type":"DRUG","name":"Standard Ibuprofen","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Treatment A","type":"EXPERIMENTAL"},{"label":"Treatment B","type":"ACTIVE_COMPARATOR"},{"label":"Treatment C","type":"PLACEBO_COMPARATOR"}],"summary":"This study will compare the ability of a single-dose of a novel ibuprofen formulation to relieve pain compared to placebo and standard ibuprofen in the treatment of episodic tension-type headache.","primaryOutcome":{"measure":"Time-weighted Sum of Pain Relief Rating and Pain Intensity Difference From 0-3 Hours (SPRID 0-3) for Ibuprofen Sodium Versus Placebo Tablet","timeFrame":"0 to 3 hours","effectByArm":[{"arm":"Placebo","deltaMin":11.2,"sd":4.9},{"arm":"Ibuprofen Sodium","deltaMin":10.8,"sd":5.3}],"pValues":[{"comp":"OG000 vs OG001","p":"0.299"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["25526232"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=AH-09-11&StudyName=Study%20Evaluating%20A%20Novel%20Ibuprofen%20Formulation%20In%20Episodic%20Tension-Type%20Headache"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":41},"commonTop":[]}}